Patients with inflammatory arthritis would benefit from vaccination against herpes zoster, with the Shingrix vaccine showing a crude effectiveness of 50%.

Dr. Mallika Marshall says that a lot of the potential risks have been inflated, causing unnecessary confusion.

British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...

What are the symptoms and how long does the vaccine last? - ANALYSIS: Experts have answered six key questions as measles ...

The European Union’s health regulator has lifted the temporary restriction on the use of French drugmaker Valneva’s ...

Join Curevo Vaccine's shingles study in East Tennessee for advanced care and a stipend. Ideal for those 50 and over. Learn more and check your eligibility.